Skip to main content

Peer Review reports

From: Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial

Original Submission
5 Dec 2020 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
5 Jan 2021 Reviewed Reviewer Report
21 Jan 2021 Reviewed Reviewer Report
7 Feb 2021 Author responded Author comments - Fatemeh Saghafi
Resubmission - Version 5
7 Feb 2021 Submitted Manuscript version 5
12 Feb 2021 Author responded Author comments - Fatemeh Saghafi
Resubmission - Version 6
12 Feb 2021 Submitted Manuscript version 6
19 Feb 2021 Author responded Author comments - Fatemeh Saghafi
Resubmission - Version 7
19 Feb 2021 Submitted Manuscript version 7
23 Feb 2021 Author responded Author comments - Fatemeh Saghafi
Resubmission - Version 8
23 Feb 2021 Submitted Manuscript version 8
24 Feb 2021 Author responded Author comments - Fatemeh Saghafi
Resubmission - Version 9
24 Feb 2021 Submitted Manuscript version 9
1 Mar 2021 Author responded Author comments - Fatemeh Saghafi
Resubmission - Version 10
1 Mar 2021 Submitted Manuscript version 10
Publishing
10 Mar 2021 Editorially accepted
24 Mar 2021 Article published 10.1186/s12879-021-05983-2

You can find further information about peer review here.

Back to article page